AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
A smart acquisition strategy has made Bristol-Meyers, which has bought seven companies since October 2007, a big player in the...
Invesco Pharmaceuticals ETF
MORNING TOP NEWS AND BLOG
